Obalon Therapeutics Inc (NASDAQ:OBLN) VP Matthew Norwood bought 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 12th. The stock was purchased at an average price of $15.00 per share, with a total value of $15,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Obalon Therapeutics Inc (NASDAQ:OBLN) opened at 12.97 on Friday. Obalon Therapeutics Inc has a 12 month low of $12.33 and a 12 month high of $15.88. The firm’s 50-day moving average is $14.47 and its 200 day moving average is $14.47.
About Obalon Therapeutics